Skip to Content

ProFunds Europe 30 Svc UEPSX

Medalist Rating as of | See ProFunds Investment Hub
  • NAV / 1-Day Return 16.37  /  −1.09 %
  • Total Assets 4.2 Mil
  • Adj. Expense Ratio
    2.780%
  • Expense Ratio 2.780%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Europe Stock
  • Investment Style Large Blend
  • Min. Initial Investment 15,000
  • Status Open
  • TTM Yield 0.00%
  • Turnover 716%

USD | NAV as of Feb 29, 2024 | 1-Day Return as of Feb 29, 2024, 1:08 AM GMT+0

Morningstar’s Analysis UEPSX

Will UEPSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in ProFunds Europe 30 Svc's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings UEPSX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 49.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S ADR

9.03 110,090
Healthcare

ASML Holding NV ADR

6.04 73,654
Technology

SAP SE ADR

5.08 61,908
Technology

HSBC Holdings PLC ADR

4.36 53,187
Financial Services

Shell PLC ADR (Representing - Ordinary Shares)

4.28 52,177
Energy

BP PLC ADR

4.25 51,870
Energy

TotalEnergies SE ADR

4.20 51,282
Energy

Anheuser-Busch InBev SA/NV ADR

4.09 49,932
Consumer Defensive

AstraZeneca PLC ADR

3.99 48,687
Healthcare

Equinor ASA ADR

3.84 46,785
Energy